Your browser doesn't support javascript.
loading
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.
Laitman, Yael; Michaelson-Cohen, Rachel; Levi, Einat; Chen-Shtoyerman, Rakefet; Reish, Orit; Josefsberg Ben-Yehoshua, Sagi; Bernstein-Molho, Rinat; Keinan-Boker, Lital; Rosengarten, Ora; Silverman, Barbara G; Perri, Tamar; Korach, Jacob; Mor, Pnina; Ephrat Ben-Baruch, Noa; Levy Lahad, Ephrat; Friedman, Eitan.
Afiliação
  • Laitman Y; Oncogenetics Unit, Institute of Human Genetics, and Meirav High Risk Clinic, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Michaelson-Cohen R; Genetics Institute and NOGA High Risk Clinic, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel.
  • Levi E; Genetics Institute and NOGA High Risk Clinic, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel.
  • Chen-Shtoyerman R; Oncogenetics Clinic, Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Hebrew University School of Medicine, Jerusalem, Israel.
  • Reish O; Genetics Institute, Assaf Harofe Medical Center, Zerifin, Israel.
  • Josefsberg Ben-Yehoshua S; Oncogenetics Clinic, Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Hebrew University School of Medicine, Jerusalem, Israel.
  • Bernstein-Molho R; Breast Cancer Unit, Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Keinan-Boker L; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Rosengarten O; Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Silverman BG; School of Public Health, University of Haifa, Haifa, Israel.
  • Perri T; Gyneco-Oncology Unit, Institute of Oncology, Shaare Zedek Medical Center, Hebrew University School of Medicine, Jerusalem, Israel.
  • Korach J; Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Mor P; Department of Gyneco-Oncology, Sheba Medical Center, Tel-Hashomer, Israel.
  • Ephrat Ben-Baruch N; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Levy Lahad E; Department of Gyneco-Oncology, Sheba Medical Center, Tel-Hashomer, Israel.
  • Friedman E; Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Cancer ; 125(5): 698-703, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30489631
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Uterinas / Judeus / Proteína BRCA1 / Proteína BRCA2 / Mutação Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Uterinas / Judeus / Proteína BRCA1 / Proteína BRCA2 / Mutação Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel